Featured Sponsor

Featured Sponsor

More Reading

November 2011

11

Previous Months April 2012 March 2012 February 2012 January 2012 December 2011 November 2011 October 2011 September 2011 August 2011 July 2011 June 2011 May 2011

Features

Feature Article: Pulmonary Toxicities of Tyrosine Kinase Inhibitors

Maajid Mumtaz Peerzada, MD, Timothy P. Spiro, MD, FACP, and Hamed A. Daw, MD

Categories:

Feature Article: A Phase I Trial of Vatalanib (PTK/ZK) in Combination With Bevacizumab in Patients With Refractory and/or Advanced Malignancies

Suzanne F. Jones, PharmD, David R. Spigel, MD, Denise A. Yardley, MD, Dana F. Thompson, MD, and Howard A. Burris, III, MD

Categories:

Columns

Advances in LLM: JAK2 Inhibitors in Myelofibrosis

Animesh Pardanani, MBBS, PhD

Categories:

Advances in Oncology: Diet and Exercise in Breast Cancer

Jennifer A. Ligibel, MD

Categories:

Advances in Drug Development: Advances in the Treatment of Neuroblastoma

Susan Cohn, MD

Categories:

Advances in Hematology: Cyclic and Chronic Neutropenia: An Update on Diagnosis and Treatment

David C. Dale, MD

Categories:

Clinical Case Study: Effectiveness of Dasatinib in Relapsed CNS, Ph+ ALL That is Refractory to Radio

Homero Gutiérrez-Aguirre, MD, Fernando García-Rodríguez, MD, Olga Cantú-Rodríguez, MD, Oscar González-Llano, MD, José Jaime-Pérez, MD, and David Gómez-Almaguer, MD

Categories:

Clinical Case Review: Which Tyrosine Kinase Inhibitor, if Any?

Guillermo J. Ruiz-Arguelles, MD, FACP, FRCP (Glasg)

Categories:

Letter From the Editor

Bruce D. Cheson, MD

Categories:

Supplements

Clinical Roundtable Monograph: Current Treatment Options for Metastatic Breast Cancer: What Now?

Hope S. Rugo, MD, Joyce A. O’Shaughnessy, MD, and Edith A. Perez, MD

Categories:

CMExpress Opportunities

Clinical Roundtable Monograph: Recent Advances and Updated Guidelines in the Management of Chemotherapy-Induced Nausea and Vomiting

Lee S. Schwartzberg, MD, FACP, Steven M. Grunberg, MD, and Mark G. Kris, MD

Clinical Roundtable Monograph: Peripheral T-Cell Lymphomas: Diagnosis and Treatment Options

Bruce D. Cheson, MD, Steven M. Horwitz, MD, and Dennis D. Weisenburger, MD